Source:http://linkedlifedata.com/resource/pubmed/id/14654898
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2003-12-5
|
pubmed:abstractText |
Akt, a down-stream target of phosphatidylinositol-3 kinase, plays multiple roles in carcinogenesis. To elucidate its role in hepatocarcinogenesis, we immunohistochemically investigated the expression of Akt protein (Akt1 and Akt2) in tumor and non-tumor tissues from 56 patients with hepatocellular carcinoma (HCC). High expression of Akt2 in HCC tissues was detected in 21 cases (38%) while Akt1 expression was moderate or less in all cases. Low expression of Akt2 was associated with histopathological differentiation, portal invasion and number of tumor nodules (p=0.026, 0.023, and 0.001, respectively). Univariate analysis showed that Akt2, histopathological differentiation, and portal vein invasion were significant prognostic factors (p=0.001, 0.028, and 0.006, respectively). Multivariate analysis revealed that in addition to histopathological differentiation, Akt2 was an independent prognostic marker (risk ratio for cancer relapse, 6.35, p=0.012). In contrast, Akt1 expression did not correlate with any clinicopathological features. Our findings suggest that Akt2, but not Akt1, is a novel independent predictor for the development and progression of HCC.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
1021-335X
|
pubmed:author |
pubmed-author:DonoKeizoK,
pubmed-author:HayashiNobuyasuN,
pubmed-author:HiraokaNobuakiN,
pubmed-author:ItoYasuhiroY,
pubmed-author:MatsuuraNariakiN,
pubmed-author:MondenMoritoM,
pubmed-author:NaganoHiroakiH,
pubmed-author:NakamoriShojiS,
pubmed-author:SakonMasatoM,
pubmed-author:UmeshitaKojiK,
pubmed-author:XuXundiX,
pubmed-author:YamamotoHirofumiH
|
pubmed:issnType |
Print
|
pubmed:volume |
11
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
25-32
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:14654898-Adult,
pubmed-meshheading:14654898-Aged,
pubmed-meshheading:14654898-Blotting, Western,
pubmed-meshheading:14654898-Carcinoma, Hepatocellular,
pubmed-meshheading:14654898-Disease-Free Survival,
pubmed-meshheading:14654898-Female,
pubmed-meshheading:14654898-Humans,
pubmed-meshheading:14654898-Immunohistochemistry,
pubmed-meshheading:14654898-Liver Neoplasms,
pubmed-meshheading:14654898-Male,
pubmed-meshheading:14654898-Middle Aged,
pubmed-meshheading:14654898-Prognosis
|
pubmed:year |
2004
|
pubmed:articleTitle |
Akt2 expression correlates with prognosis of human hepatocellular carcinoma.
|
pubmed:affiliation |
Department of Surgery and Clinical Oncology, Graduate School of Medicine, Osaka University, Osaka, Japan.
|
pubmed:publicationType |
Journal Article
|